Tokyo, Japan and Cambridge, UK - Sosei Group Corporation ('the Company'; TSE: 4565) will announce its earnings results and present operational highlights for the 12 months ended 31 December 2021 on Thursday, 10 February 2022.

The Company will host a webinar presentation with Shinichi Tamura, President and CEO, Chris Cargill, Chief Financial Officer, Miles Congreve, Chief Scientific Officer and Matt Barnes, Vice President, Drug Discovery at 6 pm JST (9 am GMT) on Thursday, 10 February 2022.

The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session.

Contact:

Hironoshin Nomura

SVP

Investor Relations and Corporate Strategy

T: +81 (0)3 6679 2178

E: Hironoshin.Nomura@SoseiHeptares.com

Shinichiro Nishishita

VP

Investor Relations

Head of Regulatory Disclosures

T: +81 (0)3 5210 3399

E: IR@SoseiHeptares.com

Citigate Dewe Rogerson

Japanese Media

Yas Fukuda

T: +81 (0)3 4360 9234

E: Yas.Fukuda@citigatedewerogerson.com

MEDiSTRAVA Consulting

International Media

Mark Swallow

David Dible

Eleanor Perkin

T: +44 (0)203 928 6900

E: SoseiHeptares@medistrava.com

(C) 2022 Electronic News Publishing, source ENP Newswire